Loading viewer...
report
Format: PDF report
This document is Ligand Pharmaceuticals' Q3 2017 quarterly report, detailing financial performance and compliance with SEC regulations.
presentation
report
Otis Spunkmeyer
report
Porsche
report
Cannon & Cannon
report
Sika